Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Savella in Irritable Bowel Syndrome
NCT01471379Phase 2Terminated
- Start
- Apr 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of milnacipran in irritable bowel syndrome (IBS). Started Apr 2012; status: terminated.
02
Drugs
milnacipran
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT01471379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471379.